Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06725758 |
Title | Two-part, First-in-Human Study on ODM-212 in Subjects with Selected Advanced Solid Tumours (TEADES) |
Acronym | TEADES |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Orion Corporation, Orion Pharma |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | GBR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Royal Marsden Hospital, London, UK | RECRUITING | London | SW36JJ | United Kingdom | Details |